Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 9038563.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Eighteen patients with familial adenomatous polyposis (FAP) who had previously undergone colectomy but had upper gastrointestinal polyps were studied in a double-blind randomized crossover trial comparing sulindac with calcium and calciferol. Sulindac produced a reduction in the crypt proliferation index in the gastric epithelium of patients but did not significantly affect duodenal mucosa. Calcium with calciferol did not have any effects on crypt proliferation index in patients with FAP.
Medical subject headings
- Adenomatous Polyposis Coli
- Calcium
- Common Bile Duct Neoplasms
- Duodenal Neoplasms
- Ergocalciferols
- Intestinal Polyps
- Stomach Neoplasms
- Sulindac